413 related articles for article (PubMed ID: 35250987)
1.
Martínez-Gómez LE; Herrera-López B; Martinez-Armenta C; Ortega-Peña S; Camacho-Rea MDC; Suarez-Ahedo C; Vázquez-Cárdenas P; Vargas-Alarcón G; Rojas-Velasco G; Fragoso JM; Vidal-Vázquez P; Ramírez-Hinojosa JP; Rodríguez-Sánchez Y; Barrón-Díaz D; Moreno ML; Martínez-Ruiz FJ; Zayago-Angeles DM; Mata-Miranda MM; Vázquez-Zapién GJ; Martínez-Cuazitl A; Barajas-Galicia E; Bustamante-Silva L; Zazueta-Arroyo D; Rodríguez-Pérez JM; Hernández-González O; Coronado-Zarco R; Lucas-Tenorio V; Franco-Cendejas R; López-Jácome LE; Vázquez-Juárez RC; Magaña JJ; Cruz-Ramos M; Granados J; Hernández-Doño S; Delgado-Saldivar D; Ramos-Tavera L; Coronado-Zarco I; Guajardo-Salinas G; Muñoz-Valle JF; Pineda C; Martínez-Nava GA; López-Reyes A
Front Immunol; 2022; 13():812940. PubMed ID: 35250987
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study.
Karakaş Çelik S; Çakmak Genç G; Pişkin N; Açikgöz B; Altinsoy B; Kurucu İşsiz B; Dursun A
J Med Virol; 2021 Oct; 93(10):5947-5952. PubMed ID: 34170561
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease.
Sabater Molina M; Nicolás Rocamora E; Bendicho AI; Vázquez EG; Zorio E; Rodriguez FD; Gil Ortuño C; Rodríguez AI; Sánchez-López AJ; Jara Rubio R; Moreno-Docón A; Marcos PJ; García Pavía P; Villa RB; Gimeno Blanes JR
PLoS One; 2022; 17(2):e0263140. PubMed ID: 35120165
[TBL] [Abstract][Full Text] [Related]
4. SNPs of ACE1 (rs4343) and ACE2 (rs2285666) genes are linked to SARS-CoV-2 infection but not with the severity of disease.
Alimoradi N; Sharqi M; Firouzabadi D; Sadeghi MM; Moezzi MI; Firouzabadi N
Virol J; 2022 Mar; 19(1):48. PubMed ID: 35305693
[TBL] [Abstract][Full Text] [Related]
5. Impact of I/D polymorphism of angiotensin-converting enzyme 1 (ACE1) gene on the severity of COVID-19 patients.
Verma S; Abbas M; Verma S; Khan FH; Raza ST; Siddiqi Z; Ahmad I; Mahdi F
Infect Genet Evol; 2021 Jul; 91():104801. PubMed ID: 33676010
[TBL] [Abstract][Full Text] [Related]
6. The impact of ACE2 polymorphisms (rs1978124, rs2285666, and rs2074192) and ACE1 rs1799752 in the mortality rate of COVID-19 in different SARS-CoV-2 variants.
Sheikhian F; Sadeghi Mofrad S; Tarashi S; Ghazanfari Jajin M; Sakhaee F; Ahmadi I; Anvari E; Sheikhpour M; Fateh A
Hum Genomics; 2023 Jun; 17(1):54. PubMed ID: 37328914
[TBL] [Abstract][Full Text] [Related]
7. Association investigations between ACE1 and ACE2 polymorphisms and severity of COVID-19 disease.
Najafi M; Mahdavi MR
Mol Genet Genomics; 2023 Jan; 298(1):27-36. PubMed ID: 36255490
[TBL] [Abstract][Full Text] [Related]
8. Gene variants rs5182, rs2074192, and rs4343 in the renin-angiotensin-aldosterone system are associated with symptom severity, higher odds of hospitalization, and death in COVID-19.
Martinez-Fierro ML; Perez-Favila A; Zorrilla-Alfaro SM; Oropeza-de Lara SA; Garza-Veloz I; Hernandez-Marquez LDS; Gutierrez-Vela EF; Delgado-Enciso I; Rodriguez-Sanchez IP
Int J Infect Dis; 2024 Jul; 144():107067. PubMed ID: 38697603
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome.
Gómez J; Albaiceta GM; García-Clemente M; López-Larrea C; Amado-Rodríguez L; Lopez-Alonso I; Hermida T; Enriquez AI; Herrero P; Melón S; Alvarez-Argüelles ME; Boga JA; Rojo-Alba S; Cuesta-Llavona E; Alvarez V; Lorca R; Coto E
Gene; 2020 Dec; 762():145102. PubMed ID: 32882331
[TBL] [Abstract][Full Text] [Related]
10. ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19.
Möhlendick B; Schönfelder K; Breuckmann K; Elsner C; Babel N; Balfanz P; Dahl E; Dreher M; Fistera D; Herbstreit F; Hölzer B; Koch M; Kohnle M; Marx N; Risse J; Schmidt K; Skrzypczyk S; Sutharsan S; Taube C; Westhoff TH; Jöckel KH; Dittmer U; Siffert W; Kribben A
Pharmacogenet Genomics; 2021 Oct; 31(8):165-171. PubMed ID: 34001841
[TBL] [Abstract][Full Text] [Related]
11. Association of ACE2 Gene Variants with the Severity of COVID-19 Disease-A Prospective Observational Study.
Sienko J; Marczak I; Kotowski M; Bogacz A; Tejchman K; Sienko M; Kotfis K
Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36231922
[TBL] [Abstract][Full Text] [Related]
12. Strong Association of Angiotensin Converting Enzyme-2 Gene Insertion/Deletion Polymorphism with Susceptibility to SARS-CoV-2, Hypertension, Coronary Artery Disease and COVID-19 Disease Mortality.
Mir MM; Mir R; Alghamdi MAA; Alsayed BA; Wani JI; Alharthi MH; Al-Shahrani AM
J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834450
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme 2 rs2285666 polymorphism and clinical parameters as the determinants of COVID-19 severity in Iranian population.
Khalilzadeh F; Sakhaee F; Sotoodehnejadnematalahi F; Zamani MS; Ahmadi I; Anvari E; Fateh A
Int J Immunogenet; 2022 Oct; 49(5):325-332. PubMed ID: 36029284
[TBL] [Abstract][Full Text] [Related]
14. Global distribution of ACE1 (rs4646994) and ACE2 (rs2285666) polymorphisms associated with COVID-19: A systematic review and meta-analysis.
Keikha M; Karbalaei M
Microb Pathog; 2022 Nov; 172():105781. PubMed ID: 36116608
[TBL] [Abstract][Full Text] [Related]
15. Genetic Association between ACE2 (rs2285666 and rs2074192) and TMPRSS2 (rs12329760 and rs2070788) Polymorphisms with Post-COVID Symptoms in Previously Hospitalized COVID-19 Survivors.
Fernández-de-Las-Peñas C; Arendt-Nielsen L; Díaz-Gil G; Gómez-Esquer F; Gil-Crujera A; Gómez-Sánchez SM; Ambite-Quesada S; Palomar-Gallego MA; Pellicer-Valero OJ; Giordano R
Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360172
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of ACE1, ACE2, and TMPRSS2 associated with COVID-19 severity: A systematic review with meta-analysis.
Saengsiwaritt W; Jittikoon J; Chaikledkaew U; Udomsinprasert W
Rev Med Virol; 2022 Jul; 32(4):e2323. PubMed ID: 34997794
[TBL] [Abstract][Full Text] [Related]
17. Single Nucleotide Variants (SNVs) of Angiotensin-Converting Enzymes (ACE1 and ACE2): A Plausible Explanation for the Global Variation in COVID-19 Prevalence.
Atiku SM; Kasozi D; Campbell K
J Renin Angiotensin Aldosterone Syst; 2023; 2023():9668008. PubMed ID: 37051471
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 Receptor ACE2 Gene Is Associated with Hypertension and Severity of COVID 19: Interaction with Sex, Obesity, and Smoking.
Hamet P; Pausova Z; Attaoua R; Hishmih C; Haloui M; Shin J; Paus T; Abrahamowicz M; Gaudet D; Santucci L; Kotchen TA; Cowley AW; Hussin J; Tremblay J
Am J Hypertens; 2021 Apr; 34(4):367-376. PubMed ID: 33386398
[TBL] [Abstract][Full Text] [Related]
19. Correlation of Angiotensin-converting Enzyme 2 Gene (rs1514283) Polymorphism with the Incidence of COVID-19.
Al-Fattli HHH; Abd-Alraoof TS
J Popul Ther Clin Pharmacol; 2022; 29(1):e122-e141. PubMed ID: 35686904
[TBL] [Abstract][Full Text] [Related]
20. Association of ACE1 I/D rs1799752 and ACE2 rs2285666 polymorphisms with the infection and severity of COVID-19: A meta-analysis.
Aziz MA; Islam MS
Mol Genet Genomic Med; 2022 Nov; 10(11):e2063. PubMed ID: 36148537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
